Global Bone Growth Stimulator Market Is Estimated to Grow About USD 1.96 Billion By 2030

The global bone growth stimulator market size was worth around USD 1.42 Billion in 2022 and is estimated to grow to about USD 1.96 Billion by 2030, with a compound annual growth rate (CAGR) of approximately 5.6 percent over the forecast period.

Bone growth stimulators are increasingly used to ameliorate the bone’s healing process and enhance bone tissue growth and development in patients who have undergone bone fusion surgeries. It is a form of treatment that is used to treat failure or delayed union or non-union fractures, spinal fusion, or ankle fusion.

These stimulators are either surgically or externally implanted into the area of the affected bone at the time of some implantation therapies which include Implantable Cardioverter-Defibrillator (ICD) and Cardiac Resynchronization Therapy (CRT). Bone fractures can also be healed by passing ultrasound and electrical waves, and hence this non-invasive bone healing treatment method is widely applied as a substitute for bone grafts. There has been ample clinical and animal research evidence to champion the widescale use of bone growth stimulators. They are usually used by the geriatric population across the globe due to the growing prevalence of arthritis and osteoporosis in them.

The global bone growth stimulator market is expected to surge exponentially due to an increase in age-related disorders among people across the globe. There has been significant growth in the number of cases of arthritis, osteoporosis, degenerative bone diseases, osteoarthritis, and rheumatoid arthritis among the elderly population around the world. Thus, a rise in the geriatric population and the increase in the prevalence of these issues in them drive the growth of the market.

Besides, growing cases of fractures, ankle injuries, and various other sports injuries have resulted in the increased adoption of bone growth stimulation devices and products, driving the growth of the market. These stimulators have extensive applications in dental, maxillofacial, spinal fusion, and others, apart from joint and fracture repair. Furthermore, there has been an exponential surge in the adoption of minimally invasive and non-invasive surgical procedures because of faster recovery, painless treatment, shorter hospitalization, minimal tissue scarring, fewer chances of infections, and economical procedures. These factors create ample opportunities for the growth of the market. However, the lack of proper medical reimbursement policies for bone stimulation and a strict approval process might restrict the growth of the market to an extent.

The global bone growth stimulator market is segmented based on product, application, distribution channel, and region.

Based on product, the market is segmented based on bone growth stimulation devices, bone morphogenetic proteins, and platelet-rich plasma. The bone growth stimulation devices segment held the largest market share in 2022 and is further expected to grow rapidly at a significant CAGR during the forecast period. The major reason for the growth of this segment is an increase in the cases of spinal deformities among people, growth in the geriatric population in various countries across the globe, and persistent improvements and technological advancements in bone growth stimulation devices. However, on the other hand, the platelet-rich plasma segment is expected to cite a notable growth rate during the forecast period. The growth of this segment is due to an increase in demand for plasma therapy in numerous orthopedic therapeutic applications.

Based on application, the market is segmented based on spinal fusion surgeries, delayed union & non-union bone fractures, oral & maxillofacial surgeries, and others. The spinal fusion segment held the largest market share in 2022 and is expected to occupy a dominant status and simultaneously grow at a remarkable CAGR during the forecast period. The major reason for the growth of this segment is the increase in the adoption of minimally invasive spinal surgeries, the rise in the cases of degenerative spinal conditions among people, growing incidences of obesity, and the surge in the popularity of spinal fusion surgery procedures in various countries around the world.

Based on region, the North American region held the largest market share in 2022 and is further predicted to grow notably at a dominant CAGR during the forecast period. The major reason for the growth of the market in this region is the immense presence of technologically advanced bone growth stimulators, the massive presence of medical device companies, the availability of advanced healthcare infrastructures, and the rise in geriatric population in the region further drives the growth of the market during the forecast period.

This review is based on a report by Zion Market Research, titled “Bone Growth Stimulators Market By Product (Bone Growth Stimulation Devices, Bone Morphogenetic Proteins, and Platelet-Rich Plasma), By Application (Spinal Fusion Surgeries, Delayed Union & Nonunion Bone Fractures, Oral & Maxillofacial Surgeries, and Others), By Distribution Channel (Hospitals & Clinics, Home Care, and Others) and By Region – Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2023 – 2030.”- Report at https://www.zionmarketresearch.com/report/bone-growth-stimulators-market

Recent Developments

• In April 2021, Orthofix signed an exclusive licensing deal with IGEA to sell the company's breakthrough soft tissue, cartilage, and bone stimulation solutions in the United States and Canada.
• In November 2020, Wright Medical was purchased by Stryker for USD 5.4 billion. Stryker's position in the orthopedics device industry was reinforced as a result of the purchase.
• In June 2020, DePuy Synthes and the AO Foundation extended their cooperation to promote patient care and outcomes via innovation and AO's independent worldwide education programs.

The global bone growth stimulator market is dominated by players such as:

• Orthofix Medical Inc.
• Zimmer Biomet
• DJO Finance LLC
• Stryker
• Bioventus LLC
• Medtronic plc
• Arthrex Inc.
• DePuy Synthes
• Isto Biologics
• Ember Therapeutics Inc.
• Terumo Corporation
• Altis Biologics (Pty) Ltd.
• Ossatec Benelux Ltd.
• Regen Lab SA
• Elizur Corporation
• ITO Co. Ltd.
• BTT Health GmbH.

Global bone growth stimulators market is segmented as follows:

By Product

• Bone Growth Stimulation Devices
• Bone Morphogenetic Proteins
• Platelet-Rich Plasma

By Application

• Spinal Fusion Surgeries
• Delayed Union & Nonunion Bone Fractures
• Oral & Maxillofacial Surgeries
• Others

By Distribution Channel

• Hospitals & Clinics
• Home Care
• Others

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa

About Us:

Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:

Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com